Work

CO214 Model Predictions for Lifetime Health Benefits of Mobocertinib and Current Treatment Options in Post-Platinum Patients with Locally Advanced or Metastatic NSCLC Harboring Egfr Exon 20 Insertion Mutation in China

Year: 2023

Type: conference-abstract

Source: Value in Health

DOI: 10.1016/j.jval.2023.03.2439

Authors: G.Y. Zuo, Y. Wang, Y. Gao, Y.J. Zhang, F.F. Zhu

Institutions: Shandong University, Chinese Academy of Medical Sciences & Peking Union Medical College, Cancer Hospital of Chinese Academy of Medical Sciences

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4380150845

Cites:

Cited by:

Related to: 10